Asia-Pacific Endotherapy Devices Market by Product - Opportunity Analysis and Industry Forecast, 2018-2024

  • ID: 4580610
  • Report
  • 154 pages
  • Allied Analytics LLP
1 of 4
The Asia-Pacific endotherapy devices market is projected to reach $1,315 million by 2024 from $826 million in 2017, growing at a CAGR of 6.9% from 2018 to 2024. Endoscopic therapy is treatments conducted using a small, tube-like instrument called endoscope. These are minimally invasive treatments that are commonly used to treat conditions such as appendicitis, colon polyps, peptic ulcer, gallbladder disease, and endometriosis.

Geriatric population is at a higher risk of diseases such as orthopedic diseases, gastrointestinal conditions, ophthalmic diseases, gastrointestinal (GI) cancer, and others. The demand for endotherapy devices is anticipated to grow correspondingly with increase in prevalence of the aforementioned cases. In addition, rise in preference for minimally invasive procedures in Asia-Pacific is anticipated to supplement the market growth. Moreover, lower complications, minimal scarring, reduced hospital stay, and rapid recovery propels the demand for technologically advanced endotherapy devices, which in turn boosts the market growth. However, dearth of skilled endoscopic technicians, risk of infection associated with endotherapy devices, and high price of endotherapy devices restrain the growth of this market.

The Asia-Pacific endotherapy devices market is segmented on the basis of product and country. Based on product, the market is categorized into GI devices & accessories, ERCP devices & accessories, and others. The GI devices & accessories segment is further classified into biopsy forceps, injection needles, polypectomy snares, graspers, hemoclips, and others. The ERCP devices & accessories segment is subsegmented into guide wire, sphincterotome, catheter, extraction basket, extraction balloon, balloon dilation, plastic stent, metal stents, and others. The other endotherapy devices & accessories segment is subdivided into mouthpiece, distal end cap, polyptrap, cleaning brush, and others. Country-wise, the market is analyzed across China, Japan, India, Singapore, Malaysia, Thailand, and rest of Asia-Pacific.

KEY MARKET BENEFITS FOR STAKEHOLDERS

This report offers a detailed quantitative analysis of the current market trends from 2017 to 2024 to identify the prevailing opportunities.
The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
In-depth analysis based on country assists in understanding the regional market to assist in strategic business planning.
The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.

KEY MARKET SEGMENTS

By Product

GI Accessories
Biopsy Forceps
Injection Needles
Polypectomy Snares
Graspers
Hemoclips
Others
ERCP Accessories
Guide Wire
Sphincterotome
Catheter
Extraction Basket
Extraction Balloon
Balloon Dilation
Plastic Stent
Metal Stents
Others
Others
Mouthpiece
Distal End Cap
Polyp Trap
Cleaning Brush
Others

By Country

China
Japan
India
Singapore
Malaysia
Thailand
Rest of Asia-Pacific

KEY PLAYERS PROFILED

HOYA Corporation
Olympus Corporation
Stryker Corporation
Boston Scientific Corporation
Fujifilm Holdings Corporation
CONMED Corporation
Medtronic Plc.
KARL STORZ GmbH & Co. KG
Smith & Nephew, Plc.
Johnson & Johnson

The other players of the Asia-Pacific endotherapy devices market include (companies not profiled in the report):

B. Braun Melsungen AG
Cook Medical
Siemens Healthcare
STERIS Corporation
Frontier Healthcare
Advanced Sterilization Products Services Inc.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porters five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Technological advancements
3.4.1.2. Rise in prevalence of diseases that require endotherapy devices
3.4.1.3. Rise in patient preference for minimally invasive surgeries
3.4.1.4. Shorter recovery time and minimal postoperative complications
3.4.2. Restrains
3.4.2.1. Dearth of trained physicians & endoscopists
3.4.2.2. Infections caused by few endotherapy
3.4.2.3. High costs associated with endotherapy devices
3.4.3. Opportunity
3.4.3.1. Unmet medical demands in the developing countries
3.4.3.2. Lucrative opportunities in the emerging economies

CHAPTER 4: ASIA-PACIFIC ENDOTHERAPY DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast, by product
4.2. GI accessories
4.2.1. Key market trends and growth opportunities
4.2.2. Market size and forecast, by country
4.2.3. Market size and forecast, by type
4.2.4. Biopsy forceps
4.2.4.1. Market size and forecast
4.2.5. Injection needles
4.2.5.1. Market size and forecast
4.2.6. Polypectomy snares
4.2.6.1. Market size and forecast
4.2.7. Graspers
4.2.7.1. Market size and forecast
4.2.8. Hemoclips
4.2.8.1. Market size and forecast
4.2.9. Other GI accessories
4.2.9.1. Market size and forecast
4.3. ERCP accessories
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by country
4.3.3. Market size and forecast, by type
4.3.4. Guidewires
4.3.4.1. Market size and forecast
4.3.5. Sphincterotome
4.3.5.1. Market size and forecast
4.3.6. Catheter
4.3.6.1. Market size and forecast
4.3.7. Extraction basket
4.3.7.1. Market size and forecast
4.3.8. Extraction balloon
4.3.8.1. Market size and forecast
4.3.9. Balloon dilators
4.3.9.1. Market size and forecast
4.3.10. Plastic stent
4.3.10.1. Market size and forecast
4.3.11. Metal stent
4.3.11.1. Market size and forecast
4.3.12. Other ERCP devices & accessories
4.3.12.1. Market size and forecast
4.4. Other endotherapy accessories
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast, by country
4.4.3. Market size and forecast, by type
4.4.4. Mouthpiece
4.4.4.1. Market size and forecast
4.4.5. Distal end cap
4.4.5.1. Market size and forecast
4.4.6. Polyp trap
4.4.6.1. Market size and forecast
4.4.7. Cleaning brush
4.4.7.1. Market size and forecast
4.4.8. Others
4.4.8.1. Market size and forecast

CHAPTER 5: ASIA-PACIFIC ENDOTHERAPY DEVICES MARKET, BY COUNTRY
5.1. Overview
5.1.1. Market size and forecast, by country
5.2. China
5.2.1. Key market trends and opportunities
5.2.2. Market size and forecast, by product
5.3. Japan
5.3.1. Key market trends and opportunities
5.3.2. Market size and forecast, by product
5.4. India
5.4.1. Key market trends and opportunities
5.4.2. Market size and forecast, by product
5.5. Singapore
5.5.1. Key market trends and opportunities
5.5.2. Market size and forecast, by product
5.6. Malaysia
5.6.1. Key market trends and opportunities
5.6.2. Market size and forecast, by product
5.7. Thailand
5.7.1. Key market trends and opportunities
5.7.2. Market size and forecast, by product
5.8. Rest of Asia-Pacific
5.8.1. Key market trends and opportunities
5.8.2. Market size and forecast, by product

CHAPTER 6: COMPANY PROFILES
6.1. Boston Scientific Corporation
6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Product portfolio
6.1.5. Business performance
6.1.6. Key strategic moves and developments
6.2. CONMED Corporation
6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product portfolio
6.2.5. Business performance
6.3. FUJIFILM Holdings Corporation
6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Product portfolio
6.3.5. Business performance
6.3.6. Key strategic moves and developments
6.4. HOYA Corporation
6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segments
6.4.4. Product portfolio
6.4.5. Business performance
6.5. Johnson & Johnson (Ethicon, Inc.)
6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.5.4. Product portfolio
6.5.5. Business performance
6.6. KARL STORZ GmbH & Co KG
6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Product portfolio
6.7. Medtronic Plc.
6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product portfolio
6.7.5. Business performance
6.8. Olympus Corporation
6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.8.4. Product portfolio
6.8.5. Business performance
6.9. Stryker Corporation
6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Product portfolio
6.9.5. Business performance
6.10. Smith & Nephew Plc.
6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Product portfolio
6.10.5. Business performance
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to a new report titled, Asia-Pacific Endotherapy Devices Market by Product and Country Opportunity Analysis and Industry Forecast, 2018-2024," the Asia-Pacific endotherapy devices market accounted for $826 million in 2017, and is expected to reach $1,315 million by 2024, registering a CAGR of 6.9% from 2018 to 2024. Japan was the highest contributor in the Asia-Pacific endotherapy devices market in 2017; however, China is expected to witness the highest growth rate during the forecast period.

Endoscopy is performed to examine abdominal pain, ulcers, digestive tract bleeding, and abnormal growths in the colon and other abdominal & gastrointestinal conditions. The minimally invasiveness of this procedure with fewer post operation complications makes it one of the most preferred and sought-after procedures in diagnostics and surgeries.

Rise in prevalence of diseases that require endotherapy procedures such as cancers and gastrointestinal diseases is one of the prime reasons that drives the growth of endotherapy devices market. In addition, increase in baby boomer generation with high risk of targeted diseases, rise in awareness about novel endotherapy devices, and patient preference for minimally invasive nature of endotherapy devices propel the market growth. Modern endotherapy techniques have revolutionized the examination and treatment of upper gastrointestinal tract (including esophagus, stomach, and duodenum) and the colon. Increase in adoption of innovative endotherapy devices along with ultrahigh-definition visualization systems further augments the market growth. However, dearth of skilled physicians & endoscopists, high cost of the sophisticated endotherapy devices, and infections caused by a few endotherapy devices impede the market growth.

Among the products, GI devices & accessories segment is the dominant segment contributing towards the growth of Asia-Pacific endotherapy devices market in 2017 owing to the increase in incidence of gastrointestinal disorders and diseases requiring the use of GI endotherapy.

Key Findings of the Asia-Pacific Endotherapy Devices Market

ERCP devices & accessories is projected to grow at the highest rate during the analysis period.
Japan dominated Asia-Pacific endotherapy devices market in 2017, and is projected to continue its dominance in future.
Guide wire is expected to grow at a highest rate in the Asia-Pacific region during the forecast period.
Graspers was the largest contributor among the GI devices & consumables in 2017.
Distal end cap generated the highest revenue in 2017, and is expected to continue its dominance in future.

The key players operating in the Asia-Pacific endotherapy devices market include Hoya Corporation, Olympus Corporation, Stryker Corporation, Boston Scientific Corporation, Fujifilm Holdings Corporation, Conmed Corporation Medtronic Plc., Karl Storz GmbH & Co. KG, Smith & Nephew, Plc., and Johnson & Johnson. Other prominent players in the value chain include B. Braun Melsungen AG, Cook Medical, Siemens Healthcare, Steris Corporation, Frontier Healthcare, and Advanced Sterilization Products Services Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll